Delivery Order SPE2DU25D9420-SPE2DU26FENSF

The Defense Logistics Agency issued a $12,177.12 firm fixed-price delivery order (4570044090) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded November 14, 2025, with completion targeted for November 18, 2025, represents one of numerous orders issued under DMS Pharmaceutical Group's recently awarded Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.

This delivery order falls under the PPV-G GEN V initiative, a $30.3 billion government-wide acquisition strategy administered by the Defense Logistics Agency to establish multiple regional prime vendor contractors. DMS Pharmaceutical Group's prime vendor contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The contractor has demonstrated substantial federal pharmaceutical supply chain experience through consistent performance on military medical supply requirements, with its product portfolio encompassing oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. No subcontractors are identified on this award.